摘要
Methodology for site-specific modification and chelate conjugation of a cyclic arginine-glycine-aspartic acid (cRGD) peptide for the preparation of a radiotracer molecular imaging agent suitable for detecting av beta 3 integrin is described. The method involves functionalizing the peptide with an aldehyde moiety and conjugation to a 1,4,7,10-tetraazacyclododecane-N,N',N?,N?-tetraacetic acid derivative that possesses an aldehyde reactive aminooxy group. The binding assay of the 111In-labeled peptide conjugate with av beta 3 integrin showed 60% bound when four equivalents of the integrin was added, a reasonable binding affinity for a monovalent modified RGD peptide.
- 出版日期2012-9